SERSTECH GROUP, 1 JULY – 30 SEPTEMBER 2026

  • Net sales amounted to KSEK 18 529 (7 765)
  • EBITDA amounted to KSEK 2 444 (-4 283)
  • EBIT amounted to KSEK 115 (-6 387)
  • Cash flow from operating activities amounted to KSEK -6 500 (-7 783)
  • Earnings per share amounted to SEK -0.00 (-0.03)
  • Earnings per average number of shares amounted to SEK -0.00 (-0.03)

SERSTECH GROUP, 1 JANUARY – 30 SEPTEMBER 2026

  • Net sales amounted to KSEK 34 713 (32 220)
  • EBITDA amounted to KSEK -4 259 (-12 651)
  • EBIT amounted to KSEK -11 674 (-18 881)
  • Cash flow from operating activities amounted to KSEK -18 048 (-22 555)
  • Earnings per share amounted to SEK -0.05 (-0.07)
  • Earnings per average number of shares amounted to SEK -0.05 (-0.07)

Message from the CEO   

Serstech delivered a strong third quarter. Revenue reached 18.5 MSEK, and we recorded a EBITDA of 2.4 MSEK. Order intake in the quarter was the second highest in the company’s history. In September, we also shipped more products in a single month than ever before.

During the quarter, we have doubled our in-house production capacity, which now represents a sales value of more than 6 MSEK per month. As a result, a substantial share of our deliveries in 2027 is expected to be produced in-house. This will support continued gross margin improvement, alongside our ongoing cost-of-goods sold reduction activities in R&D.

A shortage of electronic components is beginning to affect the market, resulting in price increases. We built inventory ahead of time, which has left inventory levels relatively high and weakened our cash position. Our inventory of components enables us to support sales and deliveries the coming quarters. We expect some minor production disruptions, but no major impact. We are currently placing component orders for delivery in Q2 2027 due to the extended delivery times.

Our cash balance is currently low, partly because we have already paid production costs to a larger extent for the larger orders delivered in September and October. The invoices from these deliveries and several smaller ones, totaling approximately 30 MSEK, are expected to be paid in November, December and January.

Oil prices remain a risk factor. A further increase in the oil prices could weaken some of our Asian customers’ ability to invest in new technology and lead to delays in ongoing business opportunities. Security and defense equipment remains a priority for most of our target countries, and we currently do not expect any cancellations of the coming tenders.

The 2027 budget process is under way. We expect to reduce both sales and R&D fixed costs next year compared with 2026, while continuing to improve gross margins through in-house production and lower overall production costs.

Pipeline growth was weak in 2025 amid uncertainty around tariffs. Since early summer this year, however, activity has moved back towards normal levels, and our pipeline is now at a record high. We expect a strong fourth-quarter order intake, giving us a solid foundation for continued growth and improved profitability in 2027.

Stefan Sandor, CEO

November 2026

For further information, please contact:

Stefan Sandor,
CEO, Serstech AB
Phone: +46 739 606 067
Email: ss@serstech.com
or
Arve Nilsson,
Chairman of the Board, Serstech AB
Phone: +45 40 35 82 65
Email: arve.nilsson@serstech.com
or visit: www.serstech.com

This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 08:45 CET on November 03, 2026.
Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).

About Serstech

Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.

Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com

Attachment

GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12

  • Researchers from six German university medical centers have received the 2026 German University Medicine Prize for their work in the GLORIA study
  • GLORIA, TME Pharma’s Phase 1/2 study, evaluates NOX-A12 in combination with radiotherapy in newly diagnosed glioblastoma patients who are resistant to chemotherapy. In an expansion cohort, NOX-A12 and radiotherapy were also combined with bevacizumab
  • The prize jury was impressed by the successful combination of basic research and clinical application and the outstanding cross-site, interdisciplinary teamwork
  • TME Pharma welcomes this independent external validation of its therapeutic approach in glioblastoma by the German medical community
  • This announcement comes as TME Pharma has reached an exclusive negotiation agreement with TMS Co., Ltd. on worldwide rights to NOX-A12

Berlin, Germany, November 3, 2026, 08.00 am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech-company with clinical assets for brain cancer and eye diseases, announces that the clinical and translational team of the GLORIA study1 have received the Award of German University Medicine 2026. It is awarded to one team each year by the German Association of Medical Faculties (MFT) and the Association of German University Hospitals (VUD), which announced the award on October 22, 2026.2

Background of the Prize

The German University Medicine Prize recognizes outstanding team achievements in university medical research, in particular innovation, the translation of research results into patient care, and their societal relevance. MFT and VUD represent the 40 medical faculties and 37 university hospitals in Germany.

The awarded GLORIA trial team comprises specialists in radiation oncology, neuro-oncology, neurosurgery, neuroradiology and neuropathology at the university medical centers of Bonn, Essen, Leipzig, Mannheim, Münster and Tübingen. Clinical leadership of the study lies with Dr. Frank Giordano (Mannheim); translational leadership lies with Dr. Julian Layer (Bonn). The prize ceremony will take place on November 24, 2026 in Berlin.

Scientific Rationale and Results Cited by the Awarding Bodies

A key mechanism of glioblastoma recurrence is the rapid re-establishment of the tumor’s blood supply after irradiation. Tumors use chemokines such as CXCL12 to rebuild their blood supply and to evade immune attack. NOX-A12 is designed to neutralize CXCL12.

According to MFT and VUD, observations from the GLORIA trial were further investigated to reveal a tumor escape mechanism. This discovery led the team to pursue a novel treatment approach that simultaneously inhibits two different pathways employed by tumors to restore blood supply. In an expansion cohort of six patients, NOX-A12 and radiotherapy were therefore combined with the anti-VEGF antibody bevacizumab to address both pathways. The combination treatment was well tolerated, and a median overall survival of 19.9 months was reported. MFT and VUD describe these results as first promising indications of the benefit of the approach. The results have been published in two articles in Nature Communications3.

“We congratulate Dr. Giordano, Dr. Layer and the entire GLORIA team on this well-deserved recognition. The German University Medicine Prize was awarded by for the way the team connected clinical observations with translational research. We regard this as a strong external validation of the scientific rationale behind TME’s development of NOX-A12 in glioblastoma: preventing the tumor from rebuilding its blood supply after radiotherapy. We look forward to building on this work in the planned randomized extension of the GLORIA study with TMS Co. Ltd. This prestigious prize and the publications in Nature Communications validate the quality of the program, and I am therefore convinced that there is enormous value to be unlocked for investors,” said Diede van den Ouden, CEO of TME Pharma.

For more information, please contact:
TME Pharma N.V.
Diede van den Ouden, CEO
ir@tmepharma.com
www.tmepharma.com

About TME Pharma

TME Pharma is a biotechnology company with two assets with potential to be developed into novel therapies for cancer and eye diseases. The Company’s lead compounds have been designed to act on the tumor microenvironment (TME) and the cancer immunity cycle by breaking tumor protection barriers against the immune system and blocking tumor repair. The Company’s two lead assets are:

  • NOX-A12 (olaptesed pegol, an anti-CXCL12 L-RNA aptamer), which has been studied (GLORIA Phase 1/2 clinical trial) in newly-diagnosed brain cancer patients who will not benefit clinically from standard chemotherapy. The US FDA and the German BfArM have approved the design of a randomized Phase 2 trial in glioblastoma, and TME Pharma was awarded Fast Track Designation by the FDA for NOX-A12 in combination with radiotherapy and bevacizumab for use in the treatment of the aggressive adult brain cancer, glioblastoma. NOX-A12 in combination with radiotherapy had also previously received orphan drug designation (ODD) for glioblastoma in the United States and glioma in Europe.
  • NOX-E36 (emapticap pegol, L-RNA aptamer inhibiting CCL2 and related chemokines), for ophthalmic diseases with a high need for well-tolerated therapies with anti-fibrotic effect.

The Company is currently seeking opportunities to secure the financial resources to unlock the value of NOX-A12 and NOX-E36. These steps include:

  • Finalizing a partnership with TMS Co., Ltd. for NOX-A12
  • Raising funds from alternative sources to secure longer financial visibility and to minimize dilution for shareholders
  • Seeking partners for NOX-E36, for example through licensing deals
  • Pursuing stable, cash-generating business opportunities to achieve positive operational cash flow for the Company
  • Leveraging tax loss carry forwards

About the GLORIA Study

The GLORIA (NCT04121455) ‘ready to go’-study is TME Pharma’s dose-escalation, Phase 1/2 study of NOX-A12 in combination with radiotherapy and bevacizumab in first-line partially resected or unresected glioblastoma (brain cancer) patients with unmethylated MGMT promoter (resistant to standard chemotherapy).

About the OPTIMUS Study

OPTIMUS (NCT04901741) is TME Pharma’s planned open-label two-arm Phase 2 study of NOX-A12 combined with pembrolizumab and nanoliposomal irinotecan/5-FU/leucovorin or gemcitabine/nab-paclitaxel in microsatellite-stable metastatic pancreatic cancer patients.

About the Preis der Deutschen Hochschulmedizin

The Preis der Deutschen Hochschulmedizin (German University Medicine Prize) is awarded by the German Association of Medical Faculties (MFT) and the Association of German University Hospitals (VUD), whose umbrella organization is Deutsche Hochschulmedizin e.V. It honors outstanding team achievements in university medical research, in particular innovation and the translation of research results into patient care. Preis der Deutschen Hochschulmedizin – Deutsche Hochschulmedizin e.V.

Further information can be found at: www.tmepharma.com.


1 NCT04121455 – GLORIA study on clinicaltrials.gov
2Press release of MFT and VUD, “Neuer Ansatz gegen aggressive Gehirntumore: GLORIA-Team erhält Preis der Deutschen Hochschulmedizin 2026,” Berlin, October 22, 2026.
3 Giordano et al 2024, Nature Comm 15:4210, Giordano 2024
Giordano et al. 2026, Nature Comm 17:3405, Giordano 2026

Attachment

EDF announces exercise of option to redeem hybrid bonds 

EDF (BBB+ stable S&P / Baa1 stable Moody’s / BBB+ stable Fitch) announces its intention to exercise its option to redeem the hybrid bonds issued on 15 September 2020 for a nominal amount of €850 million (ISIN FR0013534351) (the “Bonds”).

They will be redeemed on 15 December 2026, corresponding to their first early redemption date as defined in the Terms and Conditions of the Bonds contained in the Prospectus dated 11 September 2020.

EDF is an active issuer of debt and other types of securities. EDF regularly assesses its financing requirements and monitors national and international financial markets for opportunities to conduct additional issuances of senior debt, hybrids and/or other types of securities.

End October 2026, EDF priced a €100 million tap issue to the existing green bonds issued on 7 May 2025, with initial maturity of 7 years and a fixed coupon of 3.25% (ISIN: FR001400ZGF2).

Forward-Looking Statements:
EDF considers certain parts of this announcement to be forward-looking statements. Forward-looking statements can generally be identified by the use of forward-looking terms such as ‘believes’, ‘expects’, ‘may’, “will”, ‘could’, ‘should,’ ‘intends,’ ‘estimates,’ ‘considers,’ ‘assumes,’ ‘predicts,’ or ‘anticipates,’ as well as the negative form of such words and other words of similar meaning in connection with discussions of future operating or financial performance or strategies involving risks and uncertainties. Although EDF believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions at the time they are made, they remain uncertain by their nature and involve a number of risks and uncertainties beyond EDF’s control. Consequently, EDF cannot give any assurance that these expectations will be realised. Future events and actual results, financial or otherwise, may differ materially from the results presented in the forward-looking statements due to possible risks and uncertainties, including possible changes in the timing and execution of the transactions described in these statements.
You are advised not to place undue reliance on the forward-looking statements contained in this announcement, which are valid only as of their respective dates. Neither EDF nor any of its affiliates undertakes any obligation to publicly update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable laws and regulations.

About EDF
The EDF Group is a key player in the energy transition, as an integrated energy operator engaged in all aspects of the energy business: power generation, distribution, trading, energy sales and energy services. The Group is a world leader in low-carbon energy, with an output of 515TWh 95% decarbonised and a carbon intensity of 26.5gCO2/kWh in 2025, a diverse generation mix based mainly on nuclear and renewable energy (including hydropower). It is also investing in new technologies to support the energy transition. EDF’s raison d’être is to build a net zero energy future with electricity and innovative solutions and services, to help save the planet and drive well-being and economic development. The Group supplies energy and services to approximately 41 million customers (1) and generated consolidated sales of €113.3bn in 2025.

(1) The customer portfolio consists of electricity, gas and recurring service contracts

Attachment

All key markets achieved positive organic growth in Q3, while EBITDA was in line with expectations, supporting a refinement of Solar’s full-year EBITDA guidance to DKK 450m.

CEO Jens Andersen says:
“We delivered EBITDA in line with our expectations in Q3. Activity levels continued to improve during the quarter, resulting in positive organic growth across all key markets for the second consecutive quarter, with growth slightly ahead of our expectations.

While revenue development was encouraging, profitability continued to be affected by a highly competitive market environment, resulting in continued pressure on gross profit margins.

To further strengthen our digital focus, Solar’s Anders S. Odgaard, has been appointed Chief Technology Officer and will join the executive management team, reporting directly to the CEO. This reflects the increasing importance of technology and digital capabilities across the business.”

Q1-Q3 key financial highlights

  • All main markets delivered growth.
  • EBITDA was in line with guidance, supported by improved revenue development.
Financial highlights (DKK million) Q3 2026 Q3 2025 Q1-Q3 2026 Q1-Q3 2025
Revenue 3,321 2,815 10,069 9,056
EBITDA* 147 110 290 296
Cash flow from operating activities -155 64 -595 -20
Financial ratios (%)        
Organic growth adj. for number of working days 10.3 -2.1 3.9 1.0
EBITDA margin 4.4 3.9 2.9 3.3
Net working capital, end of period/revenue (LTM) 18.4 15.2 18.4 15.2
Gearing (NIBD/EBITDA), no. of times 5.2 3.4 5.2 3.4
Return on invested capital (ROIC) 1.9 4.4 1.9 4.4

*EBITDA adjusted for non-recurring costs amounted in Q3 2026 to DKK 158m (Q3 2025: DKK 118m)
and in Q1-Q3 2026 to DKK 370m (Q1-Q3 2025: DKK 361m).

Guidance 2026

  Refinement Previous
Revenue (DKK million) 13,600 12,900-13,400
EBITDA (DKK million)        450 400-480
Organic growth     4.5% 3.5%
EBITDA margin      3.3% 3.1% to 3.6%


Audio webcast and teleconference today
The presentation of Quarterly Report Q3 2026 will be made in English on 3 November 2026 at 11:00 CET. The presentation will be transmitted as an audio webcast and will be available at www.solar.eu. Participation will be possible via teleconference.

Access to the webcast
https://edge.media-server.com/mmc/p/5e6k8pxq

Participate in the teleconference to ask questions
If you want to participate in the teleconference, please register in advance by using this link:
https://register-conf.media-server.com/register/BI65a54dcddebf481d9f566c40a1443519
When you have registered, you will receive a dial-in number and a unique personal pin.

Contacts
CEO Jens Andersen – tel. +45 79 30 02 01
CFO Michael H. Jeppesen – tel. +45 79 30 02 62
IR Director Dennis Callesen – tel. +45 29 92 18 11

FACTS ABOUT SOLAR

Solar is a leading European sourcing and services company mainly within electrical, heating and plumbing, ventilation and climate and energy solutions. Our core business centres on product sourcing, value-adding services and optimisation of our customers’ businesses.

We facilitate efficiency improvement and provide digital tools that turn our customers into winners. We drive the green transition and provide best in class solutions to ensure sustainable use of resources.

Solar Group is headquartered in Denmark, generated revenue of approx. DKK 12.2bn in 2025 and has approx. 3,000 employees. Solar is listed on Nasdaq Copenhagen and operates under the short designation SOLAR B. For more information, please visit www.solar.eu.

Disclaimer
This announcement was published in Danish and English today via Nasdaq Copenhagen. In the event of any inconsistency between the two versions, the Danish version shall prevail.

Attachments

MALMÖ, ZETADISPLAY AB (PUBL) – 3 November 2026

ZetaDisplay is strengthening its European footprint with an expanded commercial presence in Iberia. The appointment of industry expert Álvaro Morales as Country Manager for Spain and Portugal will accelerate the company’s growth ambitions and strengthen its full-service digital signage and retail media offering across the region.

Álvaro will lead business development across both markets, bringing extensive experience in the digital signage industry, including his previous role at Scala, formerly part of STRATACACHE. With deep market knowledge and an established network of relationships with leading retailers and brands, his appointment comes as ZetaDisplay advances significant commercial discussions and identifies new opportunities for growth across the region.

Iberia represents a strategically important market for ZetaDisplay, with an established digital signage industry and increasing demand for sophisticated Retail media solutions. As retailers seek new ways to monetize their physical store environments, in-store digital advertising networks are emerging as a powerful opportunity to generate additional revenue while delivering more relevant and measurable brand experiences.

ZetaDisplay is well positioned to support this transformation through its comprehensive, turnkey approach to digital signage and retail media. Combining software, hardware, installation, content management and ongoing managed services, the company enables retailers to develop, operate and scale intelligent in-store media networks through a single, experienced partner.

At the heart of this offering is ZetaDisplay’s proprietary Engage Suite software, which provides the foundation for dynamic content delivery, audience analytics and retail media capabilities, helping retailers and advertisers connect digital campaigns with measurable in-store engagement.

Daniel Nergård, CEO of ZetaDisplay, comments:

“Iberia is an important market for ZetaDisplay and a natural next step in our European growth strategy. Digital signage is already well established in the region, and we see significant potential to build on this foundation as retailers increasingly recognise the commercial opportunities of in-store retail media.

By welcoming Álvaro to the team, we’re combining strong local market expertise with our established European technology and delivery capabilities. His industry experience and relationships will be instrumental as we strengthen our presence, develop new partnerships and bring our full-service retail media proposition to more retailers and brands across Spain and Portugal.”

The expansion into Iberia follows a period of strategic investment in ZetaDisplay’s retail media capabilities, including the acquisition of retailmediatools earlier this year.

The retail media infrastructure-as-a-service platform further strengthens ZetaDisplay’s position as a full-service provider, bringing together digital signage infrastructure, software, campaign management and advertising technology within a fully integrated, retailer-owned media ecosystem.

By connecting online advertising with physical in-store execution, the combined offering enables retailers to take greater control of their retail media operations while providing brands with new opportunities to engage consumers throughout the purchasing journey, from mobile and e-commerce to the point of sale.

With its expanded presence in Iberia and continued investment in proprietary technology and services, ZetaDisplay is accelerating its ambition to lead the next generation of digital signage and retail media across Europe.

For further questions, please contact:

Ola Sæverås, Chief Business Officer
Mobile: +47 41678234
E-Mail: ola@zetadisplay.com


About ZetaDisplay

ZetaDisplay is a leading European provider of digital communication and retail media solutions, operating over 125,000 digital displays across 50+ global markets. The enables organisations to run data-driven communication across physical environments, combing technology, content and analytics to improve performance and unlock new revenue streams.  ZetaDisplay is owned by the investment company Hanover Investors. More information about ZetaDisplay can be found on the group global website www.zetadisplay.com or for Investor relations at www.ir.zetadisplay.com or for owner information at www.hanoverinvestors.com.

Attachment

In October 2026, AS Tallink Grupp transported 476,580 passengers, representing a 2.0% increase compared to October 2025. The number of transported cargo units increased by 5.6% to 23,089 units, while the number of passenger vehicles decreased by 5.6% to 54,735 units compared to the same period a year ago.

The passenger, cargo unit and passenger vehicle volumes of AS Tallink Grupp for October 2026 were as follows:

  October 2026 October 2025 Change
Passengers 476,580 467,279 2.0%
Estonia – Finland 290,095 286,552 1.2%
Finland – Sweden 141,861 137,011 3.5%
Estonia – Sweden 44,624 43,716 2.1%
       
Cargo Units 23,089 21,855 5.6%
Estonia – Finland 17,870 15,879 12.5%
Finland – Sweden 3,718 2,698 37.8%
Estonia – Sweden 1,501 3,278 -54.2%
       
Passenger Vehicles 54,735 58,006 -5.6%
Estonia – Finland 48,882 51,856 -5.7%
Finland – Sweden 4,220 4,105 2.8%
Estonia – Sweden 1,633 2,045 -20.1%

ESTONIA – FINLAND
The October results for the Estonia-Finland route reflect the operations of the shuttle vessels MyStar and Megastar, as well as the cruise ferry Victoria I. 

FINLAND – SWEDEN
The October results for the Finland-Sweden route reflect the operations of the Helsinki-Stockholm route (the cruise ferries Silja Serenade and Silja Symphony) and the Turku-Stockholm route (the cruise ferry Baltic Princess).

ESTONIA – SWEDEN
The October results for the Estonia-Sweden route reflect the operations of the cruise ferry Baltic Queen on the Tallinn-Stockholm route. A year ago, the Estonia-Sweden operations also included the Paldiski-Kapellskär route, which was operated by the passenger vessel Superfast IX. Following the commencement of the charter agreement for the passenger vessel Superfast IX on 1 May 2026, operations on the Paldiski-Kapellskär route were discontinued.

Anneli Simm
Investor Relations Manager

AS Tallink Grupp
Sadama 5
10111 Tallinn, Estonia
E-mail: anneli.simm@tallink.ee
Phone: +372 5615 7170

Attachment

In October 2026, AS Tallink Grupp transported 476,580 passengers, representing a 2.0% increase compared to October 2025. The number of transported cargo units increased by 5.6% to 23,089 units, while the number of passenger vehicles decreased by 5.6% to 54,735 units compared to the same period a year ago.

The passenger, cargo unit and passenger vehicle volumes of AS Tallink Grupp for October 2026 were as follows:

  October 2026 October 2025 Change
Passengers 476,580 467,279 2.0%
Estonia – Finland 290,095 286,552 1.2%
Finland – Sweden 141,861 137,011 3.5%
Estonia – Sweden 44,624 43,716 2.1%
       
Cargo Units 23,089 21,855 5.6%
Estonia – Finland 17,870 15,879 12.5%
Finland – Sweden 3,718 2,698 37.8%
Estonia – Sweden 1,501 3,278 -54.2%
       
Passenger Vehicles 54,735 58,006 -5.6%
Estonia – Finland 48,882 51,856 -5.7%
Finland – Sweden 4,220 4,105 2.8%
Estonia – Sweden 1,633 2,045 -20.1%

ESTONIA – FINLAND
The October results for the Estonia-Finland route reflect the operations of the shuttle vessels MyStar and Megastar, as well as the cruise ferry Victoria I. 

FINLAND – SWEDEN
The October results for the Finland-Sweden route reflect the operations of the Helsinki-Stockholm route (the cruise ferries Silja Serenade and Silja Symphony) and the Turku-Stockholm route (the cruise ferry Baltic Princess).

ESTONIA – SWEDEN
The October results for the Estonia-Sweden route reflect the operations of the cruise ferry Baltic Queen on the Tallinn-Stockholm route. A year ago, the Estonia-Sweden operations also included the Paldiski-Kapellskär route, which was operated by the passenger vessel Superfast IX. Following the commencement of the charter agreement for the passenger vessel Superfast IX on 1 May 2026, operations on the Paldiski-Kapellskär route were discontinued.

Anneli Simm
Investor Relations Manager

AS Tallink Grupp
Sadama 5
10111 Tallinn, Estonia
E-mail: anneli.simm@tallink.ee
Phone: +372 5615 7170

Attachment

INQ Group AB (publ) (“INQ” or the “Company”), listed on Nasdaq Stockholm (ticker: INQ), announces that it has raised SEK 7,000,000 of additional capital under its existing secured convertible loan facility from a US-based investment manager.

The new financing is being completed on the same principal terms as the Company’s most recently announced tranche of the facility, including a conversion price of SEK 0.16 per share.

The additional capital follows the conversion of substantially all of the Company’s earlier convertible debt under Tranches 1 through 5. Following those conversions, approximately USD 1.55 million of convertible principal remained outstanding. The SEK 7,000,000 financing announced today will be added to that outstanding balance.

The financing further strengthens INQ’s working capital position as the Company continues the commercialisation and expansion of its consumer, enterprise and education businesses.

The new tranche has been subscribed for by a sophisticated US-based investment manager and forms part of the Company’s existing Amended and Restated Secured Convertible Agreement.

Under the terms of the new tranche, the investor is entitled to convert outstanding principal together with accrued and unpaid interest into newly issued ordinary shares in INQ at a conversion price of SEK 0.16 per share, subject to customary adjustments.

The new tranche will also be mandatorily converted at the same conversion price upon completion of a qualified equity financing of at least USD 3 million equivalent at a subscription price of at least SEK 0.22 per share.

In connection with the new tranche, the investor will receive warrants for no further consideration with a value equal to 20 per cent of the amount funded. The warrants will entitle the holder to subscribe for new ordinary shares in INQ at a subscription price of SEK 0.32 per share for a period of two years. The final number of warrants and underlying shares will be determined in accordance with the terms of the financing.

All other material terms and conditions of the new tranche are consistent with the Company’s existing convertible financing. The Company retains the right to prepay the loan, in full or in part, at any time prior to maturity without penalty.

The new tranche benefits from the same security arrangements as the existing convertible loan and remains subject to the covenants contained in the existing financing agreement.

Jonathan Faiman, Chief Executive Officer of INQ Group AB, commented:

“We are pleased to welcome a sophisticated US-based investment manager as a new investor in INQ. This SEK 7 million investment has been made on the same improved terms as our most recent financing, including a conversion price of SEK 0.16 per share.

“Following the substantial conversion of our earlier convertible debt, the Company has a significantly cleaner capital structure. The funds raised will be used as working capital to support the execution of our existing enterprise contracts and the continued rollout of our commercial activities.

“We are also looking forward to announcing further enterprise transactions during Q4 as we continue to convert our commercial pipeline into contracted business.”

Conversion and the issue of warrants and underlying shares are subject to applicable corporate approvals and will be carried out in accordance with the Swedish Companies Act and the authorisations granted by the Company’s shareholders.

For further information, please contact:

IR@inq.ai
INQ Group AB (publ)

For more information about INQ Group, please visit www.inq.ai or email ir@inq.ai.

INQ Group AB (publ), Reg. No. 556532-3929
Flaggan 1165
116 74 Stockholm

This information constitutes inside information that INQ Group AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation (EU) No 596/2014. The information was submitted for publication, through the agency of the contact person set out above, on 3 November 2026 at 08:00 CET.

About INQ Group

INQ Group AB (publ) (Nasdaq Stockholm: INQ) is a Swedish technology company developing intelligent digital writing solutions that connect natural handwriting with modern digital workflows. The INQ platform combines connected writing hardware, software and AI-enabled capabilities across consumer, enterprise and education markets.

Attachment

Please see below information about transactions made under the fourth of the 2026 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

Date on which the buy-back tranche was announced: 28 October 2026.

The duration of the buy-back tranche: 29 October 2026 to no later than 1 February 2027.

Further information on the tranche can be found in the stock market announcement on its commencement dated 28 October 2026, available here: https://newsweb.oslobors.no/message/684948

From 29 October to 30 October 2026, Equinor ASA has purchased a total of 265,300 own shares at an average price of NOK 441.0372 per share.

Overview of transactions:

Date Trading venue Aggregated daily volume (number of shares) Daily weighted average share price (NOK) Total daily transaction value (NOK)
         
29 October OSE 133,000 436.5928 58,066,842.40
  CEUX      
  TQEX      
         
30 October OSE 132,300 445.5051 58,940,324.73
  CEUX      
  TQEX      
         
Total for the period OSE 265,300 441.0372 117,007,167.13
  CEUX      
  TQEX      
         
Previously disclosed buy-backs under the tranche

OSE      
CEUX      
TQEX      
Total      
         
Total buy-backs under the tranche (accumulated)

OSE 265,300 441.0372 117,007,167.13
CEUX      
TQEX      
Total 265,300 441.0372 117,007,167.13

Following completion of the above transactions, Equinor ASA owns a total of 23,861,117 own shares, corresponding to 1.00% of Equinor ASA’s share capital, including shares under Equinor’s share savings programme (excluding shares under Equinor’s share savings programme, Equinor owns a total of 12,556,882 own shares, corresponding to 0.53% of the share capital).

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and that is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: An overview of all transactions made under the buy-back tranche that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Contact details:

Investor relations
Bård Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791

Media
Sissel Rinde, vice president Media Relations,
+47 412 60 584

Attachment

Progress on share buyback programme

ING announced today that, as part of our €1.65 billion share buyback programme announced on 29 October 2026, in total 1,050,000 shares were repurchased during the week of 29 October up to and including 30 October 2026.

The shares were repurchased at an average price of €28.57 for a total amount of €30,000,765.00. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the updates on the share buyback programme on our website. 

In line with the purpose of the programme to reduce the share capital of ING, the total number of shares repurchased under this programme to date is 1,050,000 at an average price of €28.57 for a total consideration of €30,000,765.00. To date approximately 1.82% of the maximum total value of the share buyback programme has been completed.

Note for editors
For further information on ING, please visit www.ing.com. Frequent news updates can be found in the Newsroom. Photos of ING operations, buildings and its executives are available for download at Flickr.

Press enquiries Investor enquiries
ING Group Media Relations ING Group Investor Relations
+31 20 576 5000 +31 20 576 6396
Media.Relations@ing.com Investor.Relations@ing.com

ING PROFILE
ING is a global financial institution with a strong European base, offering banking services through its operating company ING bank. The purpose of ING Bank is: empowering people to stay a step ahead in life and in business. ING Bank’s more than 60,000 employees offer retail and wholesale banking services to customers in over 100 countries.

ING Group shares are listed on the exchanges of Amsterdam (INGA NA, INGA.AS), Brussels and on the New York Stock Exchange (ADRs: ING US, ING.N).

ING aims to put sustainability at the heart of what we do. Our policies and actions are assessed by independent research and ratings providers, which give updates on them annually. ING’s ESG rating by MSCI has been upgraded from ‘AA’ to ‘AAA’ in October 2025. As of July 2026, in Sustainalytics’ view, ING’s management of ESG material risk is ‘Strong’ with an ESG risk rating of 16.7 (low risk). ING Group shares are also included in major sustainability and ESG index products of leading providers. Here are some examples: Euronext, STOXX, Morningstar and FTSE Russell.

IMPORTANT LEGAL INFORMATION
Elements of this press release contain or may contain information about ING Groep N.V. and/ or ING Bank N.V. within the meaning of Article 7(1) to (4) of EU Regulation No 596/2014 (‘Market Abuse Regulation’).

ING Group’s annual accounts are prepared in accordance with International Financial Reporting Standards as adopted by the European Union (‘IFRS- EU’). In preparing the financial information in this document, except as described otherwise, the same accounting principles are applied as in the 2025 ING Group consolidated annual accounts. All figures in this document are unaudited. Small differences are possible in the tables due to rounding.

Certain of the statements contained herein are not historical facts, including, without limitation, certain statements made of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Actual results, performance or events may differ materially from those in such statements due to a number of factors, including, without limitation: (1) changes in general economic conditions and customer behaviour, in particular economic conditions in ING’s core markets, including changes affecting currency exchange rates and the regional and global economic impact of the invasion of Russia into Ukraine and related international response measures (2) changes affecting interest rate levels (3) any default of a major market participant and related market disruption (4) changes in performance of financial markets, including in Europe and developing markets (5) fiscal uncertainty in Europe and the United States (6) discontinuation of or changes in ‘benchmark’ indices (7) inflation and deflation in our principal markets (8) changes in conditions in the credit and capital markets generally, including changes in borrower and counterparty creditworthiness (9) failures of banks falling under the scope of state compensation schemes (10) non-compliance with or changes in laws and regulations, including those concerning financial services, financial economic crimes and tax laws, and the interpretation and application thereof (11) geopolitical risks, political instabilities and policies and actions of governmental and regulatory authorities, including in connection with the invasion of Russia into Ukraine and other existing or emerging military conflicts, the risk of further military escalation, geopolitical tensions, trade restrictions and the related international response measures (12) legal and regulatory risks in certain countries with less developed legal and regulatory frameworks (13) prudential supervision and regulations, including in relation to stress tests and regulatory restrictions on dividends and distributions (also among members of the group) (14) ING’s ability to meet minimum capital and other prudential regulatory requirements (15) changes in regulation of US commodities and derivatives businesses of ING and its customers (16) application of bank recovery and resolution regimes, including write down and conversion powers in relation to our securities (17) outcome of current and future litigation, enforcement proceedings, investigations or other regulatory actions, including claims by customers or stakeholders who feel misled or treated unfairly, and other conduct issues (18) changes in tax laws and regulations and risks of non-compliance or investigation in connection with tax laws, including FATCA (19) operational and IT risks, such as system disruptions or failures, breaches of security, cyber-attacks, human error, changes in operational practices or inadequate controls including in respect of third parties with which we do business and including any risks as a result of incomplete, inaccurate, or otherwise flawed outputs from the algorithms and data sets utilized in artificial intelligence (20) risks and challenges related to cybercrime including the effects of cyberattacks and changes in legislation and regulation related to cybersecurity and data privacy, including such risks and challenges as a consequence of the use of emerging technologies, such as advanced forms of artificial intelligence and quantum computing (21) changes in general competitive factors, including ability to increase or maintain market share (22) inability to protect our intellectual property and infringement claims by third parties (23) inability of counterparties to meet financial obligations or ability to enforce rights against such counterparties (24) changes in credit ratings (25) business, operational, regulatory, reputation, transition and other risks and challenges in connection with climate change, diversity, equity and inclusion and other ESG-related matters, including data gathering and reporting and also including managing the conflicting laws and requirements of governments, regulators and authorities with respect to these topics (26) inability to attract and retain key personnel (27) future liabilities under defined benefit retirement plans (28) failure to manage business risks, including in connection with use of models, use of derivatives, or maintaining appropriate policies and guidelines (29) changes in capital and credit markets, including interbank funding, as well as customer deposits, which provide the liquidity and capital required to fund our operations, and (30) the other risks and uncertainties detailed in the most recent annual report of ING Groep N.V. (including the Risk Factors contained therein) and ING’s more recent disclosures, including press releases, which are available on www.ing.com.

This document may contain ESG-related material that has been prepared by ING on the basis of publicly available information, internally developed data and other third-party sources believed to be reliable. ING has not sought to independently verify information obtained from public and third-party sources and makes no representations or warranties as to accuracy, completeness, reasonableness or reliability of such information. This document may also discuss one or more specific transactions and/or contain general statements about ING’s ESG approach. The approach and criteria referred to in this document are intended to be applied in accordance with applicable law. Due to the fact that there may be different or even conflicting laws, the approach, criteria or the application thereof, could be different.

Materiality, as used in the context of ESG, is distinct from, and should not be confused with, such term as defined in the Market Abuse Regulation or as defined for Securities and Exchange Commission (‘SEC’) reporting purposes. Any issues identified as material for purposes of ESG in this document are therefore not necessarily material as defined in the Market Abuse Regulation or for SEC reporting purposes.  In addition, there is currently no single, globally recognized set of accepted definitions in assessing whether activities are “green” or “sustainable.” Without limiting any of the statements contained herein, we make no representation or warranty as to whether any of our securities constitutes a green or sustainable security or conforms to present or future investor expectations or objectives for green or sustainable investing. For information on characteristics of a security, use of proceeds, a description of applicable project(s) and/or any other relevant information, please reference the offering documents for such security.

This document may contain inactive textual addresses to internet websites operated by us and third parties. Reference to such websites is made for information purposes only, and information found at such websites is not incorporated by reference into this document. ING does not make any representation or warranty with respect to the accuracy or completeness of, or take any responsibility for, any information found at any websites operated by third parties. ING specifically disclaims any liability with respect to any information found at websites operated by third parties. ING cannot guarantee that websites operated by third parties remain available following the publication of this document, or that any information found at such websites will not change following the filing of this document. Many of those factors are beyond ING’s control.

Any forward-looking statements made by or on behalf of ING speak only as of the date they are made, and ING assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or for any other reason.

This document does not constitute an offer to sell, or a solicitation of an offer to purchase, any securities in the United States or any other jurisdiction.

Attachment

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.